Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Progression-free and overall survival were significantly longer with sacituzumab govitecan than with single-agent chemotherapy among patients with metastatic triple-negative bre...
Publications
View AllInstitution Info
- Type
- other
- Country
- US
- Publications
- 1
- Citations
- 1,301
External Links
Identifiers
- ROR
- https://ror.org/01e3cnp62